Nessuna connessione a internet — viene mostrata la versione salvata della pagina.

DBV Technologies

USUSD
← Allo screener
US:DBVTFLSE:0QAJPA:DBV

DBV Technologies (LSE:0QAJ) — Biotechnology: Biological Products (No Diagnostic Substances). Numero di borse in cui sono quotate le azioni della società: 3. In questa pagina: prezzo e grafico, dividendi, principali azionisti e cronologia del numero di azioni.

Informazioni sull'azienda

Sito web
dbv-technologies.com
Relazioni con gli investitori
dbv-technologies.com/investor-overview/
Settore
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Sede centrale
CHATILLON, France
Amministratore delegato
Daniel Tassé
Dipendenti
170
Fondata
2002
Azioni in circolazione
296.06 Mln al 2026-07-16
Flottante
34.94 Mln
Capitalizzazione di mercato
731.56 Mln USD
Insider
0%
Investitori istituzionali
41.66%
Settore (SIC)
Biological Products, (No Diagnostic Substances)
Forma giuridica
K65D
ISIN
FR0010417345
LEI
969500PVBQFWQKVDMD80
FCF
−171 Mln USD
Debito
510 k USD
liquidità netta
Utili e FCF — per i 12 mesi a 30.06.2026 (l'ultimo rapporto dell'azienda).
Descrizione

DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France. Its product pipeline comprising Viaskin Peanut, an immunotherapy product, which has completed Phase 3 clinical trial for the treatment of peanut allergies; and Viaskin Milk which is in Phase 1/2 clinical trial for the treatment of immunoglobulin E (IgE) mediated or cow's milk protein allergy and eosinophilic esophagitis. The company's earlier stage research programs include celiac disease. In addition, the company develops Viaskin technology platform, a platform to potentially treat food allergy. It has a collaboration with Nestlé Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of non-IgE mediated CMPA in infants and toddlers. DBV Technologies S.A. was incorporated in 2002 and is headquartered in Châtillon, France.

Borse e ticker

BorsaTickerValutaPrezzoTipo
US USA StocksDBVTF OTCUSD1.98 -10.00%azioni ordinarie
LSE London Stock Exchange0QAJ IOBEUR1.695 +0.12%azioni ordinarie
PA Euronext ParisDBV principaleEUR1.678 -0.65%azioni ordinarie

Prezzo su 3 mesi

3M1Y3Y5Y
giorno di rialzo giorno di ribassoPassa il mouse / tocca un giorno — prezzi di apertura, chiusura, massimo e minimo

Notizie di questa settimana

Ancora nessuna notizia dal sito della società.

pubblicità

Principali azionisti

DetentoreQuotaAzioniData del rapporto
MPM Bioimpact LLC5.83%3.67 Mln2026-06-30
Siren, L.L.C.2.95%1.86 Mln2026-06-30
Vivo Capital, LLC2.93%1.84 Mln2026-06-30
Perceptive Advisors Llc2.63%1.65 Mln2026-06-30
Baker Bros. Advisors, LP2.32%1.46 Mln2026-06-30
Artisan Partners Limited…2.18%1.37 Mln2026-06-30
UBS Group AG2.09%1.31 Mln2026-06-30
Morgan Stanley1.52%954 9082026-06-30
Logos Global Management…1.46%915 0002026-06-30
Patient Square Capital L…1.45%909 4742026-06-30
Artisan Partners Funds I…1.34%840 2512026-06-30
Fidelity Advisor Series…0.68%428 8002026-07-31
iShares Trust-iShares Co…0.3%942 5282026-08-31
MOHIDEEN PHARIS (Officer…≈0.23%144 9952026-01-29
iShares Trust-iShares MS…0.21%666 4802026-08-31
Ikarian Capital, LLC0.19%525 0002025-12-31
RUSSELL INVESTMENT CO-Ta…0.07%45 0892026-04-30
College Retirement Equit…0.04%117 6682026-06-30
RUSSELL INVESTMENT CO-U.…0.04%22 7072026-04-30
Fidelity Salem Street Tr…0.03%108 0802026-07-31
SPDR INDEX SHARES Fd.S-S…0.03%105 2332026-07-31
Fidelity Concord Street…0.02%51 0822026-07-31
Fidelity Concord Street…0.02%12 8552026-07-31
iShares Trust-iShares Co…0.01%41 1822026-08-31
SPDR-EUROPE-SSgA SPDR ET…0.01%36 6502026-07-31
SPDR-EUROPE-SSgA SPDR ET…0.01%28 8542026-07-31
iShares Trust-iShares MS…0.01%19 5272026-08-31
RUSSELL INVESTMENT FUNDS…0.01%5 8342026-06-30
Steward Funds Inc-Stewar…0.01%4 0512026-04-30
LORD ABBETT SECURITIES T…0%2 9732026-04-30
Trust for Professional M…0%2 2452026-05-31
Gabelli Healthcare & Wel…0%4002026-06-30